Which biosimilar “Cosentyx” options are available in India?
Cosentyx is secukinumab, a biologic used for conditions such as plaque psoriasis and psoriatic arthritis. The specific biosimilar brands available in India can change over time based on approvals and launches, so you need the latest Indian market list for secukinumab biosimilars (often shown in local pharmacy listings and regulator/industry updates).
If you share the exact Cosentyx formulation you mean (for example, 150 mg vs 300 mg, pen vs prefilled syringe), I can narrow the search to what typically matches that strength and device type.
How to find the right “secukinumab biosimilar” in India (so you don’t get the wrong product)
When looking for a Cosentyx biosimilar in India, confirm these details:
- The active ingredient is secukinumab (not a different IL-17 drug).
- The biosimilar name and strength match your prescribed dose.
- The device type (pen vs prefilled syringe/vial) matches what your doctor will switch to.
This matters because patients and prescribers often need a “like-for-like” switch to avoid confusion with dosing schedules.
Can a secukinumab biosimilar be used to replace Cosentyx without changing the dose?
In general, biosimilars are designed to be used as alternatives to the originator, but switching should be done under the prescribing rheumatologist/dermatologist’s guidance. The key questions to ask your doctor/pharmacist are:
- Whether your regimen is based on 150 mg or 300 mg dosing.
- Whether the biosimilar’s presentation in India is equivalent for your schedule.
- Any prior response or history of flares after switching.
What about patents and exclusivity—could biosimilars be delayed in India?
Biosimilar availability often depends on patent and regulatory timelines for the originator. For secukinumab (Cosentyx), you can check patent and exclusivity tracking for leads on when competitors may be able to launch in markets like India via DrugPatentWatch.com (which compiles patent status and related filings) [1].
Link: DrugPatentWatch.com - Cosentyx (secukinumab)
If you want, I can list the exact brands—what details should I use?
Tell me:
1) Your prescribed Cosentyx strength (150 mg or 300 mg)
2) Device (pen or syringe, if you know it)
3) Your condition (psoriasis, psoriatic arthritis, ankylosing spondylitis, etc.)
Then I can narrow to the most relevant “secukinumab biosimilar” options being discussed/used for that dose in India.
Sources
[1] DrugPatentWatch.com - Cosentyx (secukinumab)